Edition:
United Kingdom

I'rom Group Co Ltd (2372.T)

2372.T on Tokyo Stock Exchange

1,906JPY
22 Jan 2018
Change (% chg)

-- (--)
Prev Close
¥1,906
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
225,982
52-wk High
¥2,046
52-wk Low
¥1,099

Latest Key Developments (Source: Significant Developments)

I'rom Group unit signs iPS cell tech related license agreement with Q-State Biosciences
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - I'rom Group Co Ltd <2372.T>:Says co's wholly owned unit ID Pharma signs iPS cell (induced pluripotent stem cell) technology related license agreement with U.S.-based firm Q-State Biosciences Inc.  Full Article

I'rom Group says business and capital alliance with OKWAVE unit
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - I'rom Group Co Ltd <2372.T>:Says co signs business and capital alliance agreement with OKWAVE <<<3808.NG>>> unit OKEIOS, which is mainly engaged in medical information handling systems related design, development and sales .Says co plans to acquire shares of OKEIOS.  Full Article

I'rom Group unit announces success in production process of retinal pigment degeneration treatment
Wednesday, 20 Jul 2016 

I'rom Group Co Ltd <2372.T>:Says its wholly owned unit announced success in production process of retinal pigment degeneration treatment, under cooperation with Kyushu University.  Full Article

I'rom Group unit ID Pharma to grant technology license to KOHJIN BIO
Tuesday, 12 Jul 2016 

I'rom Group Co Ltd <2372.T>:Says unit ID Pharma to grant non-exclusive rights in Japan regarding technology license for cancer treatment by amplifing dendritic cells, to Japan-based co KOHJIN BIO.  Full Article

I'rom Group unit gets license for improvement of iPS cell preparation technology in China
Thursday, 9 Jun 2016 

I'rom Group Co Ltd <2372.T>:Says its unit ID Pharma received license for improvement of iPS cell preparation technology in China.  Full Article

I'rom Group says change of corporate auditor
Tuesday, 24 May 2016 

I'rom Group Co Ltd <2372.T>: Says it appoints Avantia GP as corporate auditor to replace PricewaterhouseCoopers Aarata .Says effective date on June 28.  Full Article

I'rom Group establishes jv in Japan
Monday, 23 May 2016 

I'rom Group Co Ltd <2372.T>: Says it established a jv named I’rom NA Co., Ltd. in Japan with a Japan-based pharmacy company . Says the jv to be engaged in Site Management Organization .Says the co to hold 70 percent stake in the jv.  Full Article

I’rom Group lowers consolidated full-year outlook for FY 2016
Monday, 2 May 2016 

I’rom Group Co.,Ltd:Says the company lowered the consolidated full-year outlook for the FY ended March 2016.Revenue forecast decreased to 4,110 million yen from 5,300 million yen.Operating profit forecast decreased to a loss of 480 million yen from a loss of 130 million yen.Ordinary profit forecast decreased to a loss of 810 million yen from a loss of 350 million yen.Net profit forecast decreased to a loss of 870 million yen from 40 million yen.Earnings per share decreased to a loss of 81.99 yen from 3.77 yen.Comments that delay of orders and transactions are the main reasons for the forecast.  Full Article

I’rom Group unit signs iPS cell preparation technology implementation promise contract
Thursday, 31 Mar 2016 

I’rom Group Co.,Ltd:Wholly owned subsidiary ID Pharma signed iPS cell preparation technology implementation promise contract with U.S-based company StemoniX to grant non-exclusive rights in U.S.  Full Article

I’rom Group subsidiary receives improvement patent license in Japan
Tuesday, 8 Mar 2016 

I’rom Group Co.,Ltd:Says subsidiary ID Pharma received improvement patent license in Japan for their sendai virus vector based iPSC production method.  Full Article

BRIEF-I'rom Group unit signs iPS cell tech related license agreement with Q-State Biosciences

* Says co's wholly owned unit ID Pharma signs iPS cell (induced pluripotent stem cell) technology related license agreement with U.S.-based firm Q-State Biosciences Inc